Skip to content
lsd.com

Indication

Malignant Solid Neoplasm

2 registered trials testing Psilocybin for this indication, none currently recruiting.

2
Registered trials
0
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Malignant Solid Neoplasm trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Malignant Solid Neoplasm

TrialStatusPhaseSubstanceSites
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring OpioidsNCT06827054 · Roswell Park Cancer InstituteNot yet recruitingPhase 2psilocybin1
Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic PainNCT05506982 · Emory UniversityCompletedPhase 1psilocybin2

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.